Private Market View

Ancilia Bio

Drug Discovery · New York, NY · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
$28.0M
Total raised
$11.1M
Last round
Early Stage VC
Apr 2023
What is Ancilia Bio worth?
$28.0Mlast known valuation

Ancilia Bio last raised an undisclosed amount in its Early Stage VC (Apr 2023).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 13 names
  • ·Watchlist + deal alerts for Ancilia Bio
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Apr 2023Early Stage VC

How Ancilia Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Ancilia Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Ancilia Bio worth?
Ancilia Bio's last known valuation is $28.0M.
How much has Ancilia Bio raised?
Ancilia Bio has raised $11.1M in total funding across 1 recorded rounds.
When did Ancilia Bio last raise?
Ancilia Bio last raised in Apr 2023 (Early Stage VC).